Glen Eagle Advisors, LLC Organovo Holdings, Inc. Transaction History
Glen Eagle Advisors, LLC
- $546 Billion
- Q2 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 12 shares of ONVO stock, worth $5. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12Holding current value
$5% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ONVO
# of Institutions
36Shares Held
2.33MCall Options Held
18.8KPut Options Held
0-
Armistice Capital, LLC New York, NY929KShares$436,6300.01% of portfolio
-
Prescott Group Capital Management, L.L.C. Tulsa, OK474KShares$222,7810.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA354KShares$166,1970.0% of portfolio
-
Black Rock Inc. New York, NY142KShares$66,8370.0% of portfolio
-
Geode Capital Management, LLC Boston, MA110KShares$51,8700.0% of portfolio
About ORGANOVO HOLDINGS, INC.
- Ticker ONVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,712,020
- Market Cap $4.09M
- Description
- Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...